tradingkey.logo
搜索

Xtant Medical Holdings Inc

XTNT
添加自选
0.320USD
-0.007-2.14%
收盘 09-18 16:00美东
45.59M总市值
24.70市盈率 TTM
盘后交易 16:10 (美东)0.320USD-0.005-1.54%

关于 Xtant Medical Holdings Inc 公司

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc 简介

公司代码XTNT
公司名称Xtant Medical Holdings Inc
上市日期Jun 30, 2010
CEOBrowne (Sean E)
员工数量217
证券类型Ordinary Share
年结日Jun 30
公司地址664 Cruiser Lane
城市BELGRADE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编59714
电话14063880480
网址https://xtantmedical.com/
公司代码XTNT
上市日期Jun 30, 2010
CEOBrowne (Sean E)

Xtant Medical Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer, Assistant Secretary
Chief Financial Officer, Assistant Secretary
742.11K
+50.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
373.75K
+57.66%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.29M
+4.44%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
971.40K
+22.19%

常见问题

Xtant Medical Holdings Inc的前五大股东是谁?

Xtant Medical Holdings Inc 的前五大股东如下:Mr. Stavros G. Vizirgianakis

哪个业务部门对Xtant Medical Holdings Inc的收入贡献最大?

在2026Q4,Orthobiologics业务部门对Xtant Medical Holdings Inc的收入贡献最大,创收17.36M,占总收入的75.38%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有